FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2526004150> ?p ?o ?g. }

• W2526004150 endingPage "622" @default.
• W2526004150 startingPage "612" @default.
• W2526004150 abstract "AIMS. Pharmacovigilance databases are usually used to detect new potential signals that are relevant for drug safety. They are seldom used for explanatory purposes, e.g. to understand the mechanisms of adverse drug reactions (ADRs). The aim of the present study was to combine pharmacovigilance and pharmacodynamic data to investigate the association between dopamine D2, serotonin 5HT2A, and muscarinic M1 receptor occupancy and the risks of antipsychotic drug (AP)-induced movement disorders. METHODS. First, we performed a case–noncase analysis using spontaneous reports from the World Health Organization (WHO) Global Individual Case Safety Report (ICSR) database, VigiBase®. We thus measured the risk of reporting movement disorders compared with all other ADRs [expressed as a reporting odds ratio (ROR)] for APs. Second, we performed a linear regression analysis to explore the association between the estimated risk of reporting for individual drugs and their receptor occupancy properties, for D2, 5HT2A and M1 receptors. RESULTS. Compared with second-generation APs, first-generation APs were found to be significantly more associated with the reporting of movement disorders in general but also with dystonia, Parkinsonism, akathisia and tardive dyskinesia, irrespective of gender. A significant inverse correlation was found between the ROR for movement disorders and the receptor occupancy of 5HT2A [P < 0.001; R 2 = 0.51; slope = A0.014; 95% confidence interval (CI) (A0.029, 0.001)], M1 (P < 0.001; R 2 = 0.56; slope = A0.014; 95% CI (A0.028, 0.001) but not D2 dopamine (P = 0.54; R 2 = 0.02; slope = A0.003; 95% CI (A0.007, 0.001) receptors. CONCLUSIONS. Using the example of AP-induced movement disorders, the present study underlines the value of the pharmacoepidemiological– pharmacodynamic method to explore ADR mechanisms in humans and real-life settings." @default.
• W2526004150 created "2016-10-07" @default.
• W2526004150 creator A5010670616 @default.
• W2526004150 creator A5017285534 @default.
• W2526004150 creator A5027339862 @default.
• W2526004150 creator A5046925107 @default.
• W2526004150 creator A5054027214 @default.
• W2526004150 creator A5057400913 @default.
• W2526004150 creator A5060691425 @default.
• W2526004150 date "2016-11-06" @default.
• W2526004150 modified "2023-10-13" @default.
• W2526004150 title "An original pharmacoepidemiological-pharmacodynamic method: application to antipsychotic-induced movement disorders" @default.
• W2526004150 cites W1594070576 @default.
• W2526004150 cites W171433794 @default.
• W2526004150 cites W1797357350 @default.
• W2526004150 cites W1966101832 @default.
• W2526004150 cites W1968223004 @default.
• W2526004150 cites W1975514455 @default.
• W2526004150 cites W1980027807 @default.
• W2526004150 cites W1988891285 @default.
• W2526004150 cites W1997078856 @default.
• W2526004150 cites W1998501106 @default.
• W2526004150 cites W2009832071 @default.
• W2526004150 cites W2009890917 @default.
• W2526004150 cites W2011475216 @default.
• W2526004150 cites W2038252445 @default.
• W2526004150 cites W2040135138 @default.
• W2526004150 cites W2047930688 @default.
• W2526004150 cites W2051750411 @default.
• W2526004150 cites W2056219222 @default.
• W2526004150 cites W2057663762 @default.
• W2526004150 cites W2060793290 @default.
• W2526004150 cites W2070619693 @default.
• W2526004150 cites W2085752173 @default.
• W2526004150 cites W2086049425 @default.
• W2526004150 cites W2125138227 @default.
• W2526004150 cites W2149950019 @default.
• W2526004150 cites W2152641996 @default.
• W2526004150 cites W2153165014 @default.
• W2526004150 cites W2153972688 @default.
• W2526004150 cites W2158299492 @default.
• W2526004150 cites W2159155203 @default.
• W2526004150 cites W2167186282 @default.
• W2526004150 cites W2179149979 @default.
• W2526004150 cites W2193975711 @default.
• W2526004150 cites W2194756172 @default.
• W2526004150 cites W2196303538 @default.
• W2526004150 cites W40242340 @default.
• W2526004150 doi "https://doi.org/10.1111/bcp.13145" @default.
• W2526004150 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5306476" @default.
• W2526004150 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27687785" @default.
• W2526004150 hasPublicationYear "2016" @default.
• W2526004150 type Work @default.
• W2526004150 sameAs 2526004150 @default.
• W2526004150 citedByCount "28" @default.
• W2526004150 countsByYear W25260041502018 @default.
• W2526004150 countsByYear W25260041502019 @default.
• W2526004150 countsByYear W25260041502020 @default.
• W2526004150 countsByYear W25260041502021 @default.
• W2526004150 countsByYear W25260041502022 @default.
• W2526004150 countsByYear W25260041502023 @default.
• W2526004150 crossrefType "journal-article" @default.
• W2526004150 hasAuthorship W2526004150A5010670616 @default.
• W2526004150 hasAuthorship W2526004150A5017285534 @default.
• W2526004150 hasAuthorship W2526004150A5027339862 @default.
• W2526004150 hasAuthorship W2526004150A5046925107 @default.
• W2526004150 hasAuthorship W2526004150A5054027214 @default.
• W2526004150 hasAuthorship W2526004150A5057400913 @default.
• W2526004150 hasAuthorship W2526004150A5060691425 @default.
• W2526004150 hasBestOaLocation W25260041501 @default.
• W2526004150 hasConcept C111113717 @default.
• W2526004150 hasConcept C112705442 @default.
• W2526004150 hasConcept C118552586 @default.
• W2526004150 hasConcept C126322002 @default.
• W2526004150 hasConcept C2776412080 @default.
• W2526004150 hasConcept C2778261627 @default.
• W2526004150 hasConcept C2779134260 @default.
• W2526004150 hasConcept C2780494398 @default.
• W2526004150 hasConcept C3019878999 @default.
• W2526004150 hasConcept C71924100 @default.
• W2526004150 hasConcept C98274493 @default.
• W2526004150 hasConceptScore W2526004150C111113717 @default.
• W2526004150 hasConceptScore W2526004150C112705442 @default.
• W2526004150 hasConceptScore W2526004150C118552586 @default.
• W2526004150 hasConceptScore W2526004150C126322002 @default.
• W2526004150 hasConceptScore W2526004150C2776412080 @default.
• W2526004150 hasConceptScore W2526004150C2778261627 @default.
• W2526004150 hasConceptScore W2526004150C2779134260 @default.
• W2526004150 hasConceptScore W2526004150C2780494398 @default.
• W2526004150 hasConceptScore W2526004150C3019878999 @default.
• W2526004150 hasConceptScore W2526004150C71924100 @default.
• W2526004150 hasConceptScore W2526004150C98274493 @default.
• W2526004150 hasIssue "3" @default.
• W2526004150 hasLocation W25260041501 @default.
• W2526004150 hasLocation W25260041502 @default.
• W2526004150 hasLocation W25260041503 @default.
• W2526004150 hasOpenAccess W2526004150 @default.
• W2526004150 hasPrimaryLocation W25260041501 @default.

• next